Hong‐Jin Kim
- Pharmacology top 10%
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Pharmacology top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- Cervical Cancer and HPV Research 7
-
- Virus-based gene therapy research 6
-
- Natural product bioactivities and synthesis 4
-
- Viral gastroenteritis research and epidemiology 4
-
- Phytochemistry and Biological Activities 4
-
- Poxvirus research and outbreaks 4
- Co-authors
- Hyoung Jin KimKiHwan BaeByung Sun MinIk‐Soo LeeMinKyun NaUi Joung YounQuan Cheng ChenHyun‐Ju Jung
- Partner nations
- South KoreaChinaJapan
In The Last Decade
Hong‐Jin Kim
42 papers receiving 807 citations
Peers
Comparison fields: 5 of 91
- Complementary and alternative medicine 70
- Pharmacology 64
- Hepatology 53
- Oncology 168
- Pharmacology 97
Countries citing papers authored by Hong‐Jin Kim
This map shows the geographic impact of Hong‐Jin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Jin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Jin Kim more than expected).
Fields of papers citing papers by Hong‐Jin Kim
This network shows the impact of papers produced by Hong‐Jin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Jin Kim. The network helps show where Hong‐Jin Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong‐Jin Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2018 | 15 | |
| 3 | 2018 | 5 | |
| 4 | 2017 | 38 | |
| 5 | 2016 | 7 | |
| 6 | [Free Paper] Surgical Strateg of T2 Gallbladder Cancer | 2011 | 0 |
| 7 | 2010 | 19 | |
| 8 | 2010 | 6 | |
| 9 | 2010 | 31 | |
| 10 | 2009 | 25 | |
| 11 | 2009 | 52 | |
| 12 | Sesquiterpene-Neolignans from the Stem Bark of Magnolia obovata and Their Cytotoxic Activity | 2008 | 4 |
| 13 | Two-Stage Hepatectomy for Bilateral Hepatocellular Carcinoma with Bile Duct Tumor Thrombi. | 2008 | 0 |
| 14 | Estimation of Liver Cell Viability after Ischemia and Reperfusion Injury in Rat Liver | 2007 | 2 |
| 15 | 2006 | 13 | |
| 16 | 2006 | 6 | |
| 17 | 수술 절제 후 재발된 결핵성 간농양의 재절제 치료 경험 | 2005 | 2 |
| 18 | 우심방내 종양전을 가진 간세포암의 심폐우회술을 이용한 수술 절제 | 2005 | 3 |
| 19 | 2004 | 19 | |
| 20 | The clinical observation of 5 cases of tinnitus with physical conditions and myology | 2001 | 1 |
About Hong‐Jin Kim
Hong‐Jin Kim is a scholar working on Hepatology, Virology and Complementary and alternative medicine, having authored 47 papers that have together received 838 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cervical Cancer and HPV Research (7 papers), Virus-based gene therapy research (6 papers), Natural product bioactivities and synthesis (4 papers), Viral gastroenteritis research and epidemiology (4 papers), Phytochemistry and Biological Activities (4 papers) and Poxvirus research and outbreaks (4 papers). The work is most often cited by research in Complementary and alternative medicine (70 citations), Pharmacology (64 citations) and Hepatology (53 citations). Hong‐Jin Kim has collaborated with scholars based in South Korea, China and Japan. Frequent co-authors include Hyoung Jin Kim, KiHwan Bae, Byung Sun Min, Ik‐Soo Lee, MinKyun Na, Ui Joung Youn, Quan Cheng Chen, Hyun‐Ju Jung, Seung Jae Lee and Se Na Kim. Their work appears in journals such as PLoS ONE, Phytochemistry and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.